NSE:SANOFICONR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NSE:SANOFICONR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Sanofi Consumer Healthcare India Ltd NSE:SANOFICONR
Sanofi Consumer Healthcare India NSE:SANOFICONR +0.03% 21 Market Cap is ₹106,108 Mil as of Jul. 08, 2026. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Sanofi Consumer Healthcare India ranks better than 76.76% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sanofi Consumer Healthcare India's share price for the quarter that ended in Mar. 2026 was ₹4298.2. Sanofi Consumer Healthcare India's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 23 Mil. Therefore, Sanofi Consumer Healthcare India's market cap for the quarter that ended in Mar. 2026 was ₹98,992 Mil.
Sanofi Consumer Healthcare India's quarterly market cap declined from Sep. 2025 (₹108,718 Mil) to Dec. 2025 (₹104,098 Mil) and declined from Dec. 2025 (₹104,098 Mil) to Mar. 2026 (₹98,992 Mil).
Sanofi Consumer Healthcare India's annual market cap increased from Dec. 2023 (₹0 Mil) to Dec. 2024 (₹113,483 Mil) but then declined from Dec. 2024 (₹113,483 Mil) to Dec. 2025 (₹104,098 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sanofi Consumer Healthcare India's Enterprise Value for Today is ₹102,604 Mil.
Sanofi Consumer Healthcare India (NSE:SANOFICONR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
The historical data trend for Sanofi Consumer Healthcare India's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Sanofi Consumer Healthcare India Annual Data | |||||||
| Trend | Dec23 | Dec24 | Dec25 | ||||
| Market Cap | 0.00 | 113,482.95 | 104,097.82 | ||||
| Sanofi Consumer Healthcare India Quarterly Data | |||||||||||
| Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | Jun25 | Sep25 | Dec25 | Mar26 | |
| Market Cap | Get a 7-Day Free Trial |
|
|
|
111,164.88 | 131,184.58 | 108,717.84 | 104,097.82 | 98,991.84 | ||
For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's Market Cap distribution charts can be found below:
* The bar in red indicates where Sanofi Consumer Healthcare India's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sanofi Consumer Healthcare India's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
| Market Cap (A: Dec. 2025 ) | = | Share Price (A: Dec. 2025 ) | * | Shares Outstanding (EOP) (A: Dec. 2025 ) |
| = | ₹4519.9 | * | 23.031 | |
| = | ₹104,098 |
Sanofi Consumer Healthcare India's Market Cap for the quarter that ended in Mar. 2026 is calculated as
| Market Cap (Q: Mar. 2026 ) | = | Share Price (Q: Mar. 2026 ) | * | Shares Outstanding (EOP) (Q: Mar. 2026 ) |
| = | ₹4298.2 | * | 23.031 | |
| = | ₹98,992 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.